Market cap
--
Revenue (TTM)
--
P/E Ratio
--
P/B Ratio
--
Div. Yield
--
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
--
-
ROE
--
-
ROCE
--
-
Industry P/E
--
-
EV/EBITDA
--
-
Debt to Equity
--
-
Book Value
--
-
EPS
--
-
Face value
--
-
Shares outstanding
--
10 Years Aggregate
CFO
$-42.83 Mln
EBITDA
$-66.33 Mln
Net Profit
$-86.08 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Zivo Bioscience Inc. Warrants (ZIVOW)
| -99.9 | -98.0 | -99.8 | -100.0 | -94.5 | -83.6 | -- |
|
BSE Sensex*
| -9.6 | -2.7 | 2.9 | -5.0 | 5.4 | 5.7 | 10.4 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Zivo Bioscience Inc. Warrants (ZIVOW)
| -92.8 | 4,303.4 | -94.8 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Zivo Bioscience Inc. Warrants (ZIVOW)
ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company... operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan. Read more
-
President, CEO & Chairman of the Board
Mr. John B. Payne
-
President, CEO & Chairman of the Board
Mr. John B. Payne
-
Headquarters
Troy, MI
-
Website
FAQs for Zivo Bioscience Inc. Warrants (ZIVOW)
What is the current share price of Zivo Bioscience Inc Warrants (ZIVOW) Today?
The share price of Zivo Bioscience Inc Warrants (ZIVOW) is $0.00 (NASDAQ) as of 01-Jun-2026 14:45 EDT. Zivo Bioscience Inc Warrants (ZIVOW) has given a return of -94.5% in the last 3 years.
What is the current PB & PE ratio of Zivo Bioscience Inc Warrants (ZIVOW)?
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
-0.05 |
-0.14 |
2024 |
-0.46 |
-12.03 |
2023 |
-0.01 |
-0.03 |
2022 |
-0.14 |
-113.83 |
2021 |
-0.94 |
1.47 |
What is the 52 Week High and Low of Zivo Bioscience Inc Warrants (ZIVOW)?
The 52-week high and low of Zivo Bioscience Inc Warrants (ZIVOW) are Rs 0.95 and Rs 0.00 as of 06-Sep-2026.
What is the market cap of Zivo Bioscience Inc Warrants (ZIVOW)?
Zivo Bioscience Inc Warrants (ZIVOW) has a market capitalisation of $ 35 Mln as on 01-Jun-2026. As per SEBI classification, it is a company.
Should I invest in Zivo Bioscience Inc Warrants (ZIVOW)?
Before investing in Zivo Bioscience Inc Warrants (ZIVOW), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.